Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial-Reference-Cited by-同舟云学术

Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double‐blind, placebo‐controlled, proof‐of‐concept trial

Published:2019-03-31 Issue:9 Volume:176 Page:1251-1267
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Hobbs Adrian J.¹^ORCID,Moyes Amie J.¹,Baliga Reshma S.¹,Ghedia Dipa²,Ochiel Rachel²,Sylvestre Yvonne³,Doré Caroline J.³^ORCID,Chowdhury Kashfia³,Maclagan Kate³,Quartly Harriet L.³,Sofat Reecha⁴,Smit Angelique²,Schreiber Benjamin E.²,Coghlan Gerry J.²,MacAllister Raymond J.⁵

Affiliation:

1. William Harvey Research Institute, Barts and The London School of Medicine and DentistryQueen Mary University of London London UK

2. Department of CardiologyRoyal Free London NHS Foundation Trust London UK

3. Comprehensive Clinical Trials UnitUniversity College London London UK

4. Centre for Clinical PharmacologyRayne Institute London UK

5. Dorset County Hospital NHS Foundation Trust Dorset UK

Funder

British Heart Foundation

Publisher

Wiley

Subject

Pharmacology